社论。

Q2 Pharmacology, Toxicology and Pharmaceutics
Andrea Brancale
{"title":"社论。","authors":"Andrea Brancale","doi":"10.1177/2040206617724304","DOIUrl":null,"url":null,"abstract":"Last May, the International Society for Antiviral Research (ISAR) held the 30th International Conference on Antiviral research in Atlanta, Georgia, USA. This is one of the most important international meetings in our research field and it attracts scientists from different scientific backgrounds, from chemistry to biology. ISAR is the premier international organization completely dedicated to antiviral research and Antiviral Chemistry and Chemotherapy is proud to be one of the society’s official journals. Our aim is to consolidate this relationship in the next few years and to explore new opportunities to work closely together. Indeed, in Atlanta, we have offered an open access fees waiver to the winner of the Young Researcher poster award. This recognizes the effort of AVCC, echoed by ISAR, in supporting early stage researchers in a crucial moment of their career, when they are building their international profile. We believe that through these kinds of initiatives, we can increase our visibility and reputation in the antiviral research community and, at the same time, do what we do best: helping the scientists in the field to make their work visible and accessible. We will continue to offer the publication fees waiver as part of the ISAR Young investigator Poster award in the future and we will keep working with ISAR to further expand our collaboration. Following up on the support for early stage researcher, AVCC is always very keen to engage with them and involve them in our activities. Acting as Guest Editor in one of our Special Collections, for example, can provide the young scientists with a new experience and insight in the editorial world. Indeed, our initial collections will be edited by three very bright rising stars in the antiviral field: Jerome Deval, Joana Duarte and Giuseppe La Regina. We are now planning a new series of Special Collections and we are looking for new potential Guest Editors. For this reason, we would be very happy to hear your ideas and if you think you would be interested in acting as editor, do not hesitate in contacting us. Finally, I will now leave you to what AVCC is really about: the science. We have some very interesting paper just published in this issue and I strongly encourage you to read them and share them with your colleagues.","PeriodicalId":7960,"journal":{"name":"Antiviral Chemistry and Chemotherapy","volume":"25 2","pages":"19"},"PeriodicalIF":0.0000,"publicationDate":"2017-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2040206617724304","citationCount":"0","resultStr":"{\"title\":\"Editorial.\",\"authors\":\"Andrea Brancale\",\"doi\":\"10.1177/2040206617724304\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Last May, the International Society for Antiviral Research (ISAR) held the 30th International Conference on Antiviral research in Atlanta, Georgia, USA. This is one of the most important international meetings in our research field and it attracts scientists from different scientific backgrounds, from chemistry to biology. ISAR is the premier international organization completely dedicated to antiviral research and Antiviral Chemistry and Chemotherapy is proud to be one of the society’s official journals. Our aim is to consolidate this relationship in the next few years and to explore new opportunities to work closely together. Indeed, in Atlanta, we have offered an open access fees waiver to the winner of the Young Researcher poster award. This recognizes the effort of AVCC, echoed by ISAR, in supporting early stage researchers in a crucial moment of their career, when they are building their international profile. We believe that through these kinds of initiatives, we can increase our visibility and reputation in the antiviral research community and, at the same time, do what we do best: helping the scientists in the field to make their work visible and accessible. We will continue to offer the publication fees waiver as part of the ISAR Young investigator Poster award in the future and we will keep working with ISAR to further expand our collaboration. Following up on the support for early stage researcher, AVCC is always very keen to engage with them and involve them in our activities. Acting as Guest Editor in one of our Special Collections, for example, can provide the young scientists with a new experience and insight in the editorial world. Indeed, our initial collections will be edited by three very bright rising stars in the antiviral field: Jerome Deval, Joana Duarte and Giuseppe La Regina. We are now planning a new series of Special Collections and we are looking for new potential Guest Editors. For this reason, we would be very happy to hear your ideas and if you think you would be interested in acting as editor, do not hesitate in contacting us. Finally, I will now leave you to what AVCC is really about: the science. We have some very interesting paper just published in this issue and I strongly encourage you to read them and share them with your colleagues.\",\"PeriodicalId\":7960,\"journal\":{\"name\":\"Antiviral Chemistry and Chemotherapy\",\"volume\":\"25 2\",\"pages\":\"19\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1177/2040206617724304\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Antiviral Chemistry and Chemotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/2040206617724304\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antiviral Chemistry and Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/2040206617724304","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。
Editorial.
Last May, the International Society for Antiviral Research (ISAR) held the 30th International Conference on Antiviral research in Atlanta, Georgia, USA. This is one of the most important international meetings in our research field and it attracts scientists from different scientific backgrounds, from chemistry to biology. ISAR is the premier international organization completely dedicated to antiviral research and Antiviral Chemistry and Chemotherapy is proud to be one of the society’s official journals. Our aim is to consolidate this relationship in the next few years and to explore new opportunities to work closely together. Indeed, in Atlanta, we have offered an open access fees waiver to the winner of the Young Researcher poster award. This recognizes the effort of AVCC, echoed by ISAR, in supporting early stage researchers in a crucial moment of their career, when they are building their international profile. We believe that through these kinds of initiatives, we can increase our visibility and reputation in the antiviral research community and, at the same time, do what we do best: helping the scientists in the field to make their work visible and accessible. We will continue to offer the publication fees waiver as part of the ISAR Young investigator Poster award in the future and we will keep working with ISAR to further expand our collaboration. Following up on the support for early stage researcher, AVCC is always very keen to engage with them and involve them in our activities. Acting as Guest Editor in one of our Special Collections, for example, can provide the young scientists with a new experience and insight in the editorial world. Indeed, our initial collections will be edited by three very bright rising stars in the antiviral field: Jerome Deval, Joana Duarte and Giuseppe La Regina. We are now planning a new series of Special Collections and we are looking for new potential Guest Editors. For this reason, we would be very happy to hear your ideas and if you think you would be interested in acting as editor, do not hesitate in contacting us. Finally, I will now leave you to what AVCC is really about: the science. We have some very interesting paper just published in this issue and I strongly encourage you to read them and share them with your colleagues.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Antiviral Chemistry and Chemotherapy
Antiviral Chemistry and Chemotherapy Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
5.20
自引率
0.00%
发文量
5
审稿时长
15 weeks
期刊介绍: Antiviral Chemistry & Chemotherapy publishes the results of original research concerned with the biochemistry, mode of action, chemistry, pharmacology and virology of antiviral compounds. Manuscripts dealing with molecular biology, animal models and vaccines are welcome. The journal also publishes reviews, pointers, short communications and correspondence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信